Expert panel opinion on the optimal educational pathway for diabetes educators for training people with type 1 diabetes on the MiniMed™ 780G system: a Delphi consensus
Expertenpanel-Meinung zum optimalen Bildungsweg für Diabetesberater:innen zur Schulung von Menschen mit Typ-1-Diabetes zum MiniMed™ 780G-System: Delphi-Konsens
Acta Diabetologica · 29.10.2024 · 62 (5) · 685-694
DOI: 10.1007/s00592-024-02388-w ↗Auf einen Blick
Ein Expertenpanel entwickelte per Delphi-Konsens einen Bildungsweg für Diabetesberater:innen zur Schulung am MiniMed™ 780G-System. Ein strukturierter Ausbildungsweg wurde von allen Panelmitgliedern befürwortet.
Fragestellung
Welcher Bildungsweg ist für Diabetesberater:innen optimal, um Menschen mit Typ-1-Diabetes zum MiniMed™ 780G-System zu schulen?
Methode
Delphi-Konsens mit 11 Expert:innen aus der EMEA-Region; Konsensschwelle ≥ 75 %.
Ergebnisse
11 Expert:innen mit im Mittel 16,3 Jahren klinischer Erfahrung und Betreuung von mindestens 50 PWT1D mit MiniMed™ 780G. 100 % befürworteten Mentoring und In-field-Training, 90 % Präsenztraining mit E-Learning-Modulen.
Schlussfolgerung der Autor:innen
Der von dem Expert Panel entwickelte Bildungsweg zeigte, dass Fähigkeiten auf fortgeschrittenem Niveau nötig sind und Mentoring für deren Entwicklung zentral ist.
Kernaussagen
- Strukturierter Bildungsweg für Diabetesberater:innen wurde per Delphi-Konsens erstellt
- 100 % befürworteten Mentoring und In-field-Training
- 90 % befürworteten Präsenztraining mit E-Learning-Modulen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Delphi-Studie in der Zeitschrift Acta Diabetologica, online erschienen am 29.10.2024. Verfasst von Geraldine Gallen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Department, Kings College Hospital, London, UK. geraldinegallen@nhs.net. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Patient Education as Topic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medtronic Europe.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
The MiniMed™ 780G system is an advanced insulin pump system incorporating an AHCL (Advanced Hybrid Close Loop) algorithm that automatically adjusts insulin delivery based on glucose levels. All guidelines recommend the use of Automated Insulin Delivery therapy for people with type 1 diabetes (PWT1D) and they highlight that a specifically trained and expert team should provide training on HCL systems for PWT1D, but none of the publications detail the curriculum profile that diabetes educators should have. This paper aims to establish a consensus on the optimal educational pathway for diabetes educators on the MiniMed™ 780G system.
Methods
An Expert Panel (EP) of 11 key opinion educators in diabetes technology in the EMEA area was assembled. Using the Delphi method, a consensus questionnaire based on the literature research was created, discussed and validated by the EP members. An agreement level of ≥ 75% was considered a strong consensus.
Results
EP members had on average 16.3 years of clinical experience and followed at least 50 PWT1D using the MiniMed™ 780G system. All EP members agreed that a structured educational pathway to train diabetes educators in the use of the MiniMed™ 780G system is needed. 100% of the EP members agreed that the pathway should include a mentorship programme and in-field training; 90% agreed on using face-to-face training with the support of e-learning modules. The EP members believed that minimum competency standards for diabetes educators around the principles of diabetes care and education are needed.
Conclusion
The educational pathway created by the EP showed that skills are needed at an advanced level and that mentorship in developing these skills is critical. This pathway is vital for supporting the implementation of diabetes technology into everyday life and can remove barriers and increase access to PWT1D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes Department, Kings College Hospital, London, UK. geraldinegallen@nhs.net.
- Department of Public Health Sciences and Paediatrics, Regina Margherita Children's Hospital, Turin, Italy.
- Endocrinology and Nutrition, University Hospital Mútua Terrassa, Terrassa, Spain.
- Diabetes Department, Maccabi Health Fund, Tel Aviv, Israel.
- Independent Diabetes Nurse, Lausanne, Switzerland.
- Centre for Diabetes and Endocrinology, Johannesburg, South Africa.
Förderung
- Medtronic Europe
Zitieren
APA
Gallen, G., Rosso, A., Alonso-Carril, N., Arbeli, S., Bahon, V., Brown, V., Endlich, K., Gulotta, F., Hansart, A., Jolley, A., Jussila, R., Stefanowicz-Bielska, A., & Cardano, P. (2024). Expert panel opinion on the optimal educational pathway for diabetes educators for training people with type 1 diabetes on the MiniMed™ 780G system: a Delphi consensus. Acta Diabetologica, 62(5), 685-694. https://doi.org/10.1007/s00592-024-02388-w
Vancouver
Gallen G, Rosso A, Alonso-Carril N, Arbeli S, Bahon V, Brown V, et al. Expert panel opinion on the optimal educational pathway for diabetes educators for training people with type 1 diabetes on the MiniMed™ 780G system: a Delphi consensus. Acta Diabetologica. 2024;62(5):685-694. doi:10.1007/s00592-024-02388-w
BibTeX
@article{Gallen2024,
author = {Gallen, Geraldine and Rosso, Alice and Alonso-Carril, Núria and Arbeli, Sima and Bahon, Virginie and Brown, Vanessa and Endlich, Kerstin and Gulotta, Francesca and Hansart, Audrey and Jolley, Amy and Jussila, Rea and Stefanowicz-Bielska, Anna and Cardano, Paola},
title = {Expert panel opinion on the optimal educational pathway for diabetes educators for training people with type 1 diabetes on the MiniMed™ 780G system: a Delphi consensus},
journal = {Acta Diabetologica},
year = {2024},
volume = {62},
number = {5},
pages = {685--694},
doi = {10.1007/s00592-024-02388-w}
}
EUVIMED